Close
Digital Health & Ai Innovation summit 2026
APE 2026

Featured

McKesson Reports Fiscal 2018 Third-Quarter Results

McKesson Corporation reported that revenues for the third quarter ended December 31, 2017, were $53.6 billion, up 7% compared to $50.1 billion a year ago....

CAR T-Cell Therapy Provides High Remission Rate in Paediatric and Young Adult Patients with Relapsed or Refractory B-Cell ALL

A global, phase II study results published in February 1st, 2018 issue of The New England Journal of Medicine indicate that anti-CD19 chimeric antigen receptor...

Price cap on cardiac stents stifling innovation, harming patients: Manufacturers

As the first anniversary of the price capping of cardiac stents draws near, medical device manufacturers and related associations assembled at the National Pharmaceutical Pricing...

Philips debuts fully integrated suite of enhanced patient monitoring solutions in U.S. market

Royal Philips , a global leader in health technology announced the launch of its next-generation Patient Monitoring solution in the U.S. The enterprise-wide system consists...

Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): A multicentre, open-label, single-arm, phase 2 trial

Regimens based on ibrutinib alone and lenalidomide and rituximab in combination show high activity in patients with relapsed or refractory mantle cell lymphoma. We hypothesised...

The growing trend of open innovation approaches is stimulating health innovation

Standfirst:Collaborations between academia, industry and government are increasingly creating the kinds of fertile environments where health innovation can sprout and flourish. Singapore’s thriving entrepreneurial, start-up environment...

The risks of text messaging in hospitals & healthcare environments

The adoption of mobile technology within healthcare environments has increased significantly in recent years, as more and more clinicians turn to their devices to coordinate...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »